Latest News

 Filter by Provider

iRobot shares drop after revealing preliminary Q4 results, with projected revenue of $171 million and expected GAAP operating loss of $59 million.

Morgan Stanley upgrades RH to Overweight with $530 price target, citing positive inflection and long-term fundamentals.

Lantheus shares are trading lower by 5.4% during Monday's session. The company announced a $350 million acquisition.

Shares of BioNTech fell 4% on Monday. Vaccine stocks are volatile after Moderna's updated revenue guidance for 2025, which fell below analyst expectations.

Activities and deals include “Be your own pizza chef” and takeout specials all week: Jan 13th – Jan 17th

Apple's iPhones lost ground in China as domestic players gained traction in 2024. Counterpoint predicts market recovery in 2024 after decline.

Amid LA wildfires, analyst picks Douglas Emmett Inc as a long-term beneficiary of rebuilding efforts. Office space demand expected to increase.

The revised projection largely reflects declining COVID-19 vaccine demand, as fewer people seek boosters amid the ongoing shift to an endemic phase.

IonQ Inc (NYSEIONQ) shares are trading lower Monday alongside several other quantum computing stocks as the quantum sector continues to face selling pressure on the back of cautious commentary from Nvidia Corp NASDAQ:NVDANASDAQNVDA)

We are looking for downside into what appears to be an Intermediate wave (2). If we were to break and found resistance on top of 400$ we could expect further downside towards MG2 of 300 at 380-372-365.

Startup OpenAI on Monday joined its biggest investor, Microsoft, in proposing AI infrastructure projects.

Shares of Rigetti Computing are down 18% Monday morning. Nvidia CEO Jensen Huang's recent comments raised doubts about the near-term viability of quantum computing.

American Eagle shares gained after announcing a low single-digit comparable sales increase for fourth quarter-to-date, surpassing expectations.

ADANI PORTS and SEZ Indian Stocks Elliott Wave Technical Analysis

The deal includes a 270 million cubic feet per day (MMcf/d) processing plant and a rich gas header system in Williston Basin, North Dakota.

Gold has shown remarkable resilience despite rising bond yields and a strengthening US dollar.

Analysts with Needham say Instacart stock is a buy, as the company is growing strong despite competition from Uber, Amazon and DoorDash.

Europe's largest pension fund sold its Tesla stake in the third quarter, missing out on future gains. A look at the reasons why it sold.

Bitcoin (CRYPTO: BTC) broke new ground in 2024 with the launch of its spot exchange-traded products (ETPs). According to JPMorgan analyst Kenneth B. Worthington, the impact was game-changing.

GSK's $1 billion acquisition of IDRx includes IDRX-42, a precision therapy for GIST. Phase 1/1b trial shows 53% ORR in early treatment stages.

Elf Beauty's stock price doesn't reflect its growth potential, according to Morgan Stanley. Analyst upgraded rating to Overweight with $153 PT.

Eli Lilly plans to acquire Scorpion's PI3Kα program for $2.5 billion, reinvesting Mounjaro and Zepbound profits to expand its precision medicines pipeline.

Quantum computing stocks fell again after Mark Zuckerberg joined Nvidia's CEO in claiming the technology is far off from commercial usage.

The company also had a setback for its CMV vaccine.

Urban Outfitters and American Eagle also reported holiday sales.

Brent crude could reach $90 per barrel as Goldman Sachs warns of potential oil price risks due to U.S. sanctions on Russian energy sector.

USD/CHF gains 0.25%, bolstered by reduced expectations of Federal Reserve easing after strong December job figures.

Novavax shares are trading lower by 9.8% during Monday's session. Shares of vaccine stocks are trading lower after Moderna issued 2025 revenue guidance below analyst estimates.